Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript

Genetic Technologies Limited (NASDAQ:GENE) Quarterly Investor Webinar January 27, 2021 7:30 PM ET Company Participants Stephanie Ottens - Investor Relations George Muchnicki - Acting Chief Executive Officer Peter Rubinstein - Chairman Richard Allman - Chief Scientific Officer Conference Call Participants Stephanie Ottens Good morning and welcome everyone to Genetic Technologies Quarterly Investor Webinar. And we have the pleasure this morning to have from Genetic, Dr. George Muchnicki, Acting CEO on the res ...